Skip to main content
Premium Trial:

Request an Annual Quote

BC Platforms Teams With SAS on Analysis of Genomic, Other Patient Data

NEW YORK – BC Platforms said on Tuesday that it has partnered with analytics giant SAS Institute to provide life sciences and healthcare organizations with curated genomics and other patient data. The companies expect that the partnership will help them break down data silos and ultimately improve prediction of health outcomes.

Zurich-based BC Platforms and Cary, North Carolina-based SAS said that they already have many of the same clients in pharmaceutical development and healthcare delivery. The firms said they will "discover new ways to derive insights" from genomics and other patient data, such as imaging and blood chemistry.

"Big data is not close to reaching its full potential in health," Nino da Silva, deputy managing director for BC Platforms, said in a statement. "But through our partnership, which provides access to carefully curated patient data, including genomic data, we will deliver tangible results that will make a difference to drug development, healthcare provision, and patient outcomes."

Scott McClain, principal industry consultant at SAS, added that the partnership "ensures users get closer to the high-quality genomics and real-world data networks they need to make bold discoveries that drive progress."

The new collaboration adds to BC Platforms' other recent partnerships, including with Singapore Health Services, the African Institute of Everyone Genome, and Cure Duchenne.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.